Clinical Trials

ctDNA Study, PI Dr. Arthur Topilow Circulating Tumor DNA, Micro-RNA, and Exosomal DNA is Predictive of Relapse of Triple Receptor Negative Breast Cancer.


Study ID
ctDNA Study-PI Dr. Arthur Topilow

NCT Number
(Click on the NCT number for more information about the trial)

Research Study Number
2018-0425

Principle Investigator
Dr. Arthur Topilow

Phase
Pilot/Feasibility

Sponsor
HackensackUMC


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now